Table 1 Characteristics of all patients included (n = 798), and as per type of operation.
Variable | All patients n = 798 (100%) | Laparoscopic cholecystectomy (LC) n = 629 (78.8%) | Laparoscopic sleeve gastrectomy (LSG) n = 169 (21.2%) | P value |
|---|---|---|---|---|
Age (years) | 40 (32–48) | 41 (33–50) | 36 (29-43.5) | < 0.001 |
Sex Male Female | 154 (19.3) 644 (80.7) | 117 (18.6) 512 (81.4) | 37 (21.9) 132 (78.1) | 0.336 |
BMI (kg/m2) | 34.9 (29.8–41.2) | 33.4 (29.4–38.7) | 43.9 (34.7–50.1) | < 0.001 |
ALT (IU/L) | 18 (13.4–26.5) | 18.1 (14–27) | 16.1 (12.1–24.0) | 0.015 |
AST (IU/L) | 18 (15–22) | 18.0 (15.0–22.0) | 16.5 (13.1–21.0) | 0.012 |
ALP (IU/L) | 77 (63–97) | 79.4 (63.1–99.0) | 73.0 (57.2–93.0) | 0.027 |
Total Bilirubin (mg/dL) | 0.57 (0.50–0.80) | 0.59 (0.50–0.80) | 0.54 (0.50–0.82) | 0.625 |
Albumin (g/dL) | 4.3 (4.1–4.5) | 4.3 (4.1–4.5) | 4.3 (4.1–4.5) | 0.857 |
Platelets (x106/mL) | 253 (208.8–304) | 254 (208.5-300.9) | 253 (209.5-309.5) | 0.633 |
Hb (g/dL) | 12.4 (11.5–13.3) | 12.4 (11.5–13.3) | 12.4 (11.5–13.4) | 0.924 |
RBCs (x103/mL) | 4.7 (4.4-5.0) | 4.7 (4.4–5.1) | 4.7 (4.4-5.0) | 0.454 |
WBCs (x103/mL) | 7.2 (5.5–9.3) | 7.1 (5.6–9.1) | 7.2 (5.3–9.7) | 0.849 |
LSM (kPa, range 1.5–75) | 4.9 (4.0-6.4) | 4.8 (3.9–6.1) | 5.8 (4.4–8.7) | < 0.001 |
CAP (dB/m, range 100–400) | 263 (214–311) | 258 (213–301) | 298 (225–342) | < 0.001 |
LIVER BIOPSY Fibrosis stage (METAVIR) | ||||
F0 | 434 (54.4) | 323 (51.4) | 111 (65.7) | 0.011 |
F1 | 315 (39.5) | 263 (41.8) | 52 (30.8) | |
F2 | 32 (4.0) | 28 (4.5) | 4 (2.4) | |
F3 | 9 (1.1) | 9 (1.4) | 0 (0.0) | |
F4 | 8 (1.0) | 6 (1.0) | 2 (1.2) | |
LIVER BIOPSY Steatosis stage | ||||
S0 | 580 (72.7) | 521 (82.8) | 59 (34.9) | < 0.001 |
S1 | 157 (19.7) | 86 (13.7) | 71 (42.0) | |
S2 | 56 (7.0) | 20 (3.2) | 36 (21.3) | |
S3 | 5 (0.6) | 2 (0.3) | 3 (1.8) | |
